Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
03/2003
03/06/2003CA2458375A1 Substituted-heteroaryl-7-aza¬2.2.1|bicycloheptanes for the treatment of disease
03/06/2003CA2458230A1 Method and composition for treatment of ocular hypertension and glaucoma
03/06/2003CA2458135A1 Single dose azithromycin for treating respiratory infections
03/06/2003CA2458132A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture
03/06/2003CA2458131A1 Jnk activation inhibitor
03/06/2003CA2457885A1 Antimicrobial and anti-inflammatory peptides
03/06/2003CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003CA2457532A1 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003CA2455773A1 Substituted-aryl 7-aza¬2.2.1|bicycloheptanes for the treatment of disease
03/06/2003CA2421499A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the same and pharmaceutical agent containing the same as active ingredient
03/05/2003WO2002020566A2 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3?
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288298A2 TRNA synthetase from Staphylococcus aureus
03/05/2003EP1288224A1 Therapeutic peptide derivatives
03/05/2003EP1288223A1 Therapeutic peptide derivatives
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1287364A2 Diagnostics and therapeutics for macular degeneration-related disorders
03/05/2003EP1287121A2 Extracellular domain of ryk protein for regulating angiogenesis
03/05/2003EP1287115A2 Retinal pigment epithelial cell lines with extended life-span and their applications
03/05/2003EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives
03/05/2003EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286672A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1115406A4 Sustained release, and comfortable ophthalmic composition and method for ocular therapy
03/05/2003EP0973514B1 In vivo polymerizable ophthalmic compositions
03/05/2003EP0895474A4 Liquid eye drop composition
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0575524B1 Products for treating glaucoma
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400903A Novel combination of non sedative anti histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis
03/05/2003CN1400009A Slowly-releasing medicine membrane for curing perforation of tympanic membrane
03/05/2003CN1400004A Chinese medicine preparation for curing chronic conjunctivitis
03/05/2003CN1399995A Chinese medicine preparation containing cortex fraxini and its preparation method
03/05/2003CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/05/2003CN1102398C Eye ointment for curing myopia and its production process
03/05/2003CN1102389C External-use drops for earand its prepn. method
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
03/04/2003US6528522 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
03/04/2003US6528516 Methods for reducing intraocular pressure using A3 adenosine receptor antagonists
03/04/2003US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
03/04/2003US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation
03/04/2003US6528048 Ophthalmic solutions
02/2003
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016505A2 Kgf polypeptide compositions
02/27/2003WO2003016314A1 1-alkyl 0r 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
02/27/2003WO2003016279A1 Fused-polycyclic compounds
02/27/2003WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
02/27/2003WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
02/27/2003WO2003015795A1 Physiological method of improving vision
02/27/2003WO2003015794A1 Methods and compositions for treating apoptosis associated disorders
02/27/2003WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
02/27/2003WO2003015772A1 Inhibitors of polyq-aggregation
02/27/2003WO2003015759A2 Treatment of hyperproliferative conditions of body surfaces
02/27/2003WO2003015667A1 Method and intra sclera implant for treatment of glaucoma and presbyopia
02/27/2003WO2003015516A1 Compositions and methods for treatment of mitochondrial diseases
02/27/2003WO2003004098A8 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
02/27/2003WO2003002123A3 Therapeutic combinations for the treatment of hormone deficiencies
02/27/2003WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/27/2003WO2002098350A3 Pyranoindazoles and their use for the treatment of glaucoma
02/27/2003WO2002098278A3 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
02/27/2003WO2002095704A9 Use of nf-kappa-b inhibitors to treat dry eye disorders
02/27/2003WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/27/2003WO2002090325A3 Benzazepinone alpha v integrin receptor antagonists
02/27/2003WO2002089813A3 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
02/27/2003WO2002068383A3 Thiol-modified hyaluronan
02/27/2003WO2002064590A3 Carboline derivatives
02/27/2003WO2002060388A3 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
02/27/2003WO2002056863A3 Sustained release drug delivery devices
02/27/2003WO2002046193A3 Heterocyclic ether substituted imidazoquinolines
02/27/2003WO2002038157A3 Inhibitors of thromboxane formation and action
02/27/2003WO2002028865A3 Condensed pyridoindole derivatives
02/27/2003WO2002022111A3 Combination of lipoic acids and conjugated acids for treating diabetic disorders
02/27/2003WO2002020028A3 Method and composition for enhancing vision
02/27/2003WO2002004605A3 Stimulation of cellular regeneration and differentiation in the inner ear
02/27/2003WO2002000691A3 Polynucleotides and polypeptides encoded thereby
02/27/2003WO2001098471A3 Human phosphodiesterases
02/27/2003US20030041339 Animal model for use in the treatment of vision defects
02/27/2003US20030040640 For use as anti- inflammatory analgesics, in therapy of immune disorders, as anti- cancer and anti-tumor agents, and therapy of cardiovascular disease, skin redness, and viral infection
02/27/2003US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
02/27/2003US20030040541 Administering bismuth subgallate to inhibit the production of nitric oxide synthases (NOS)
02/27/2003US20030040535 Tetrazole compounds as thyroid receptor ligands
02/27/2003US20030040530 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containning them
02/27/2003US20030040529 Combined agents for treatment of glaucoma
02/27/2003US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity
02/27/2003US20030040518 For therapy of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons degeneration of lesioned and damaged neurons
02/27/2003US20030040517 For use in therapy of pain, fever, inflammation of a variety of conditions and diseases
02/27/2003US20030040509 Methods and compositions for treating diseases associated with excesses in ACE
02/27/2003US20030039689 Prodrug in polymer matrix; insertion into body
02/27/2003US20030039629 Espression enhancer for protein synthesis inhibitory genes
02/27/2003CA2458643A1 Nucleic-acid associated proteins
02/27/2003CA2458068A1 Methods and compositions for treating apoptosis associated disorders
02/27/2003CA2457781A1 Kgf polypeptide compositions
02/27/2003CA2457453A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
02/27/2003CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 531